NEW YORK (GenomeWeb News) – Nanosphere has closed a public offering of its common stock, raising approximately $35.3 million.

The Northbrook, Ill.-based molecular diagnostics firm sold 5,405,000 shares of common stock at a price of $7 per share. The total number of shares sold includes 705,000 shares that comprised the over-allotment option.

Nanosphere said that it will use the proceeds for general corporate purposes and working capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.